Cargando…
Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective
The right to health as a basic human right- and access to medicine as a part of it- have been a matter of attention for several decades. Also the responsibilities of different parties- particularly pharmaceutical companies- in realization of this right has been emphasized by World Health Organizatio...
Autores principales: | Ahmadiani, Saeed, Nikfar, Shekoufeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855755/ https://www.ncbi.nlm.nih.gov/pubmed/27141958 http://dx.doi.org/10.1186/s40199-016-0151-z |
Ejemplares similares
-
Short and long term impacts of COVID-19 on the pharmaceutical sector
por: Ayati, Nayyereh, et al.
Publicado: (2020) -
From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2014) -
Doctors’ opinions of information provided by Libyan pharmaceutical company representatives
por: Alssageer, Mustafa A., et al.
Publicado: (2012) -
Donations Made and Received: A Study of Disclosure Practices of Pharmaceutical Companies and Patient Groups in Canada
por: Lexchin, Joel
Publicado: (2021) -
Achieving Equitable Access to Medicines and Health Services: A COVID-19-time Recalled Matter
por: Mousavi, Taraneh, et al.
Publicado: (2021)